Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Cardiac MRI assessment of atrial fibrosis in atrial fibrillation: implications for diagnosis and therapy.

Higuchi K, Akkaya M, Akoum N, Marrouche NF.

Heart. 2014 Apr;100(7):590-6. doi: 10.1136/heartjnl-2013-303884. Epub 2013 Apr 25. No abstract available.

PMID:
23619986
2.

Atrial fibrillation. Left atrial fibrosis--a promising stroke risk factor?

Gaita F, Blandino A.

Nat Rev Cardiol. 2011 Jun;8(6):307-8. doi: 10.1038/nrcardio.2011.63. Epub 2011 Apr 19.

PMID:
21502961
3.

Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences.

Hirsh BJ, Copeland-Halperin RS, Halperin JL.

J Am Coll Cardiol. 2015 May 26;65(20):2239-51. doi: 10.1016/j.jacc.2015.03.557. Review.

4.

Assessment and impact of cardiac fibrosis on atrial fibrillation.

Akoum N, Marrouche N.

Curr Cardiol Rep. 2014 Aug;16(8):518. doi: 10.1007/s11886-014-0518-z. Review.

PMID:
24950676
5.

Serum YKL-40 as a Marker of Left Atrial Fibrosis Assessed by Delayed Enhancement MRI in Lone Atrial Fibrillation.

Canpolat U, Aytemir K, Hazirolan T, Özer N, Oto A.

Pacing Clin Electrophysiol. 2015 Dec;38(12):1386-95. doi: 10.1111/pace.12729. Epub 2015 Sep 12.

PMID:
26256257
6.
7.

Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.

Navaravong L, Barakat M, Burgon N, Mahnkopf C, Koopmann M, Ranjan R, Kholmovski E, Marrouche N, Akoum N.

J Cardiovasc Electrophysiol. 2015 Jan;26(1):21-7. doi: 10.1111/jce.12530. Epub 2014 Sep 26.

PMID:
25142836
8.

MRI of the left atrium: predicting clinical outcomes in patients with atrial fibrillation.

Daccarett M, McGann CJ, Akoum NW, MacLeod RS, Marrouche NF.

Expert Rev Cardiovasc Ther. 2011 Jan;9(1):105-11. doi: 10.1586/erc.10.177. Review.

9.

Cardiac magnetic resonance T1 mapping of left atrial myocardium.

Beinart R, Khurram IM, Liu S, Yarmohammadi H, Halperin HR, Bluemke DA, Gai N, van der Geest RJ, Lima JA, Calkins H, Zimmerman SL, Nazarian S.

Heart Rhythm. 2013 Sep;10(9):1325-31. doi: 10.1016/j.hrthm.2013.05.003. Epub 2013 May 2.

10.

Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.

Akkaya M, Higuchi K, Koopmann M, Burgon N, Erdogan E, Damal K, Kholmovski E, McGann C, Marrouche NF.

Europace. 2013 Dec;15(12):1725-32. doi: 10.1093/europace/eut147. Epub 2013 May 27.

PMID:
23711578
11.

Automated analysis of atrial late gadolinium enhancement imaging that correlates with endocardial voltage and clinical outcomes: a 2-center study.

Malcolme-Lawes LC, Juli C, Karim R, Bai W, Quest R, Lim PB, Jamil-Copley S, Kojodjojo P, Ariff B, Davies DW, Rueckert D, Francis DP, Hunter R, Jones D, Boubertakh R, Petersen SE, Schilling R, Kanagaratnam P, Peters NS.

Heart Rhythm. 2013 Aug;10(8):1184-91. doi: 10.1016/j.hrthm.2013.04.030. Epub 2013 May 16.

12.

Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population.

Cochet H, Mouries A, Nivet H, Sacher F, Derval N, Denis A, Merle M, Relan J, Hocini M, Haïssaguerre M, Laurent F, Montaudon M, Jaïs P.

J Cardiovasc Electrophysiol. 2015 May;26(5):484-92. doi: 10.1111/jce.12651. Epub 2015 Apr 22.

PMID:
25727248
13.

The role of MRI-detected left atrial delayed enhancement in selecting the right patient and choosing the optimal strategy for catheter ablation of atrial fibrillation.

Shah D.

J Cardiovasc Electrophysiol. 2011 Jan;22(1):23-4. doi: 10.1111/j.1540-8167.2010.01904.x. Epub 2010 Sep 14. No abstract available.

PMID:
20840463
14.

Magnetic resonance imaging for evaluation of left atrial lesions after catheter ablation of atrial fibrillation.

Igawa O.

Circ J. 2010 Aug;74(8):1524-5. Epub 2010 Jul 14. No abstract available.

15.

Left atrium and the imaging of atrial fibrosis: catch it if you can!

Tan TC, Koutsogeorgis ID, Grapsa J, Papadopoulos C, Katsivas A, Nihoyannopoulos P.

Eur J Clin Invest. 2014 Sep;44(9):872-81. doi: 10.1111/eci.12305. Review.

PMID:
25066356
16.

Association of left atrial function and left atrial enhancement in patients with atrial fibrillation: cardiac magnetic resonance study.

Habibi M, Lima JA, Khurram IM, Zimmerman SL, Zipunnikov V, Fukumoto K, Spragg D, Ashikaga H, Rickard J, Marine JE, Calkins H, Nazarian S.

Circ Cardiovasc Imaging. 2015 Feb;8(2):e002769. doi: 10.1161/CIRCIMAGING.114.002769.

17.

[Atrial fibrillation as consequence and cause of structural changes of atria].

Aparina OP, Chikhireva LN, Stukalova OV, Mironova NA, Kashtanova SIu, Ternovoĭ SK, Golitsyn SP.

Kardiologiia. 2014;54(11):57-64. Review. Russian.

PMID:
25902660
18.

Atrial fibrosis: a risk stratifier for atrial fibrillation.

Velagapudi P, Turagam MK, Leal MA, Kocheril AG.

Expert Rev Cardiovasc Ther. 2013 Feb;11(2):155-60. doi: 10.1586/erc.12.174. Review.

PMID:
23405837
19.

Quantitative tissue-tracking cardiac magnetic resonance (CMR) of left atrial deformation and the risk of stroke in patients with atrial fibrillation.

Inoue YY, Alissa A, Khurram IM, Fukumoto K, Habibi M, Venkatesh BA, Zimmerman SL, Nazarian S, Berger RD, Calkins H, Lima JA, Ashikaga H.

J Am Heart Assoc. 2015 Apr 27;4(4). pii: e001844. doi: 10.1161/JAHA.115.001844.

20.

Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation.

McGann C, Kholmovski E, Blauer J, Vijayakumar S, Haslam T, Cates J, DiBella E, Burgon N, Wilson B, Alexander A, Prastawa M, Daccarett M, Vergara G, Akoum N, Parker D, MacLeod R, Marrouche N.

J Am Coll Cardiol. 2011 Jul 5;58(2):177-85. doi: 10.1016/j.jacc.2011.04.008.

Supplemental Content

Support Center